OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel genes and sex differences in COVID-19 severity
Raquel Cruz, Silvia Diz‐de Almeida, Miguel López de Heredia, et al.
Human Molecular Genetics (2022) Vol. 31, Iss. 22, pp. 3789-3806
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
Erola Pairo‐Castineira, Konrad Rawlik, Andrew D. Bretherick, et al.
Nature (2023) Vol. 617, Iss. 7962, pp. 764-768
Open Access | Times Cited: 120

Genetic susceptibility to severe COVID-19
Claudio Cappadona, Valeria Rimoldi, Elvezia Maria Paraboschi, et al.
Infection Genetics and Evolution (2023) Vol. 110, pp. 105426-105426
Open Access | Times Cited: 26

Genome-wide association studies of COVID-19: Connecting the dots
Leonardo Capistrano Ferreira, Carlos Eduardo Maia Gomes, João Firmino Rodrigues-Neto, et al.
Infection Genetics and Evolution (2022) Vol. 106, pp. 105379-105379
Open Access | Times Cited: 31

Next-generation sequencing of host genetics risk factors associated with COVID-19 severity and long-COVID in Colombian population
Mariana Angulo-Aguado, Juan Camilo Carrillo-Martínez, Nora Constanza Contreras-Bravo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6

A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist
Jérémie Le Pen, Gabrielle Paniccia, Volker Kinast, et al.
PLoS Biology (2024) Vol. 22, Iss. 9, pp. e3002767-e3002767
Open Access | Times Cited: 6

The humoral and cellular response to mRNA SARS‐CoV ‐2 vaccine is influenced by HLA polymorphisms
Francesca Bertinetto, Paola Magistroni, G. Mazzola, et al.
HLA (2023) Vol. 102, Iss. 3, pp. 301-315
Open Access | Times Cited: 15

HLA‐A*11:01 and HLA‐C*04:01 are associated with severe COVID‐19
Patricia Castro‐Santos, Óscar Martínez-Nieto, José A. Riancho, et al.
HLA (2023) Vol. 102, Iss. 6, pp. 731-739
Open Access | Times Cited: 15

Post-Covid condition and clinic characteristics associated with SARS-CoV-2 infection: a 2-year follow-up to Brazilian cases
Nayara Sousa da Silva, Nathália Kelly de Araújo, Katiusse Alves dos Santos, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14

Canadian COVID-19 host genetics cohort replicates known severity associations
Elika Garg, Paola Arguello-Pascualli, Olga Vishnyakova, et al.
PLoS Genetics (2024) Vol. 20, Iss. 3, pp. e1011192-e1011192
Open Access | Times Cited: 5

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2
Luis A. Pérez‐Jurado, Alejandro Cáceres, Laura Balagué-Dobón, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 4

Shaping current European mitochondrial haplogroup frequency in response to infection: the case of SARS-CoV-2 severity
José Luis Cabrera-Alarcón, Raquel Cruz, Marina Rosa-Moreno, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access

Gender differences in sequelae from COVID-19 infection
Trinity Eimer, Sonia Villapol
Elsevier eBooks (2025), pp. 599-613
Closed Access

Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 Patients
Alex Serra-Llovich, Natàlia Cullell, Olalla Maroñas, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 553-553
Open Access

Sex‐stratified genome‐wide meta‐analysis identifies novel loci for cognitive decline in older adults
Vibha Acharya, Kang‐Hsien Fan, Beth E. Snitz, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access

Human Genomics of COVID-19 Pneumonia: Contributions of Rare and Common Variants
Aurélie Cobat, Qian Zhang, Laurent Abel, et al.
Annual Review of Biomedical Data Science (2023) Vol. 6, Iss. 1, pp. 465-486
Open Access | Times Cited: 10

Stratified analyses refine association between TLR7 rare variants and severe COVID-19
Jannik Boos, Caspar I. van der Made, Gayatri Ramakrishnan, et al.
Human Genetics and Genomics Advances (2024) Vol. 5, Iss. 4, pp. 100323-100323
Open Access | Times Cited: 3

The immunogenetics of COVID-19
Anshika Srivastava, Jill A. Hollenbach
Immunogenetics (2022) Vol. 75, Iss. 3, pp. 309-320
Open Access | Times Cited: 14

COVID‐19 and non‐alcoholic fatty liver disease: Biological insights from multi‐omics data
Carlos J. Pirola, Silvia Sookoian
Liver International (2023) Vol. 43, Iss. 3, pp. 580-587
Closed Access | Times Cited: 7

Is SARS-COV-2 associated with alpha-1 antitrypsin deficiency?
Carlota Rodríguez‐García, Emilio Rodríguez‐Ruiz, Alberto Ruano‐Raviña, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 2, pp. 711-717
Open Access | Times Cited: 7

Genetic Determinants of the Acute Respiratory Distress Syndrome
Eva Suarez-Pajes, Eva Tosco‐Herrera, Melody Ramirez-Falcon, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3713-3713
Open Access | Times Cited: 7

COVID‐19 and the risk of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis
Hanyu Zhang, Zengyuan Zhou
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 12, pp. 1953-1961
Open Access | Times Cited: 12

Molecular Profile of Variants Potentially Associated with Severe Forms of COVID-19 in Amazonian Indigenous Populations
Rita de Cássia Calderaro Coelho, Carlliane Lima e Lins Pinto Martins, Lucas Favacho Pastana, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 359-359
Open Access | Times Cited: 2

Follow-up of Immune Response in Patients with Common Variable Immunodeficiency following SARS-CoV-2 Vaccination
Juan Francisco Gutiérrez‐Bautista, Irene Díaz-Alberola, María Tarriño, et al.
Clinical & Experimental Immunology (2024) Vol. 217, Iss. 3, pp. 253-262
Closed Access | Times Cited: 2

Innate Immunity in Cardiovascular Diseases—Identification of Novel Molecular Players and Targets
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 1, pp. 335-335
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top